(Q47930580)

6 February 2018

title

Comparing costs of illness of multiple sclerosis in three different years: A population-based study. (English)

1 reference

6 February 2018

author

Hanna Gyllensten

1

1 reference

6 February 2018

Kristina Alexanderson

3

object named as

Kristina Alexanderson

1 reference

6 February 2018

6

Petter Tinghög

1 reference

6 February 2018

author name string

Michael Wiberg

2

1 reference

6 February 2018

Emilie Friberg

4

1 reference

6 February 2018

Jan Hillert

5

1 reference

6 February 2018

publication date

1 March 2017

1 reference

6 February 2018

Multiple Sclerosis Journal

published in

1 reference

6 February 2018

page(s)

1352458517702549

1 reference

6 February 2018

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Cost of disorders of the brain in Europe 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Costs and quality of life of multiple sclerosis in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Promoting remyelination in multiple sclerosis: current drugs and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Oral disease-modifying therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Registers of the Swedish total population and their use in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Part 3: International evaluation of Swedish public health research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

External review and validation of the Swedish national inpatient register

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

The Swedish MS registry – clinical support tool and scientific resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Contribution of intangible costs to the economic burden of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Cost of Illness of Multiple Sclerosis - A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

Economic burden of multiple sclerosis: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

The socioeconomic consequences of multiple sclerosis: a controlled national study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517702549

21 January 2018

Identifiers

DOI

10.1177/1352458517702549

1 reference

6 February 2018

PubMed ID

28367678

1 reference

6 February 2018